Using our Arestat™ technology platform, we are developing next generation therapies for our proprietary pipeline and in partnership with leading pharmaceutical and biotech companies

Our Products

Our treatments for people living with chronic disease are designed to advance patient care and improve clinical outcomes

Our Partners

We work with many of the top 20 leading pharmaceutical companies to improve their products, find solutions or create next generation products

Latest News and Events

  • 17th December 2020

    ARECOR’S PARTNER INHIBRX EXERCISES ITS OPTION TO LICENSE A NEW FORMULATION DEVELOPED BY ARECOR

  • 16th December 2020

    Arecor Announces Publication Of Phase I Data For AT247 in Diabetes Care

  • 14th December 2020

    First patient dosed in Phase I clinical trial of Ultra-Concentrated Rapid Acting Insulin candidate, AT278, for diabetes